Reviewed by The Peptide Dispatch Editorial Team · Last reviewed July 6, 2026
Gonadorelin (GnRH) is a sexual health peptide, at the fda approved stage in the published literature. Synthetic version of natural GnRH that stimulates pituitary release of LH and FSH. Used for fertility and hormone testing.
Synthetic version of natural GnRH that stimulates pituitary release of LH and FSH. Used for fertility and hormone testing.
| Research Status | FDA approved |
|---|---|
| Half-Life | 2-4 minutes |
| Administration | Subcutaneous injection |
| Doses Reported in Published Studies | 100-500 mcg |
Activates GnRH receptors in pituitary to release gonadotropins in pulsatile manner.
Synthetic version of natural GnRH that stimulates pituitary release of LH and FSH. Used for fertility and hormone testing.
Activates GnRH receptors in pituitary to release gonadotropins in pulsatile manner.
Gonadorelin is at the following stage in the published literature: FDA approved. All information is for research and educational purposes only.
Reported half-life: 2-4 minutes.
Reported administration route in the literature: Subcutaneous injection. This is not a recommendation for human use.
Educational content, not medical advice. Effects described are drawn from cited research in study subjects.